Paper6996481
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.
Shulman HM and 9 others. Am J Med, 1980. Cited by 2,398 papers, by iCite.
Cite this record
ConductScience Library. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Papers, record 6996481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6996481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Graft vs Host Disease | Major topic |
| Adolescent | |
| Adult | |
| Autoantibodies | |
| Child | |
| Child, Preschool | |
| Chronic Disease | |
| Digestive System Diseases | |
| Female | |
| Graft vs Host Reaction | |
| Histocompatibility | |
| Humans | |
| Infant | |
| Liver Function Tests | |
| Lung Diseases | |
| Male | |
| Prognosis | |
| Skin Diseases | |
| Transplantation, Homologous |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00412360 | Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) | Background |
Source ClinicalTrials.gov
Cited by926
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,398 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42839030 | GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42839030 | PubMed |
| 42821361 | Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study. | Stem Cells Transl Med | 2026 | https://conductscience.org/library/papers/42821361 | PubMed |
| 42730201 | The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia. | J Hematol | 2026 | https://conductscience.org/library/papers/42730201 | PubMed |
| 42686993 | Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42686993 | PubMed |
| 42575207 | Phenotype-Specific Associations between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/42575207 | PubMed |
| 42443469 | Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42443469 | PubMed |
| 42373850 | T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42373850 | PubMed |
| 42170327 | Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42170327 | PubMed |
| 42050760 | GATA2 Mutations Predict Poor Prognosis in Transplanted Myeloid Neoplasms. | Cancer Med | 2026 | https://conductscience.org/library/papers/42050760 | PubMed |
| 41983154 | Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases. | J Hematol | 2026 | https://conductscience.org/library/papers/41983154 | PubMed |
| 41912754 | Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41912754 | PubMed |
| 41876847 | Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41876847 | PubMed |
| 41835915 | Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients. | Clin Hematol Int | 2026 | https://conductscience.org/library/papers/41835915 | PubMed |
| 41807605 | Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41807605 | PubMed |
| 41795054 | Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41795054 | PubMed |
| 41351865 | Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT. | Am J Hematol | 2026 | https://conductscience.org/library/papers/41351865 | PubMed |
| 41109900 | Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41109900 | PubMed |
| 41102401 | Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41102401 | PubMed |
| 40830236 | Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party. | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/40830236 | PubMed |
| 40810334 | Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation. | Br J Haematol | 2025 | https://conductscience.org/library/papers/40810334 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6996481
GET https://conductscience.org/api/papers/v1/6996481/cited_by?page=2